Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$150M |
| 2 |
ExxonMobil
XOM
|
+$121M |
| 3 |
Visa
V
|
+$94.9M |
| 4 |
Columbia Banking Systems
COLB
|
+$94.4M |
| 5 |
GE HealthCare
GEHC
|
+$89.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$320M |
| 2 |
JPMorgan Chase
JPM
|
+$209M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$96.7M |
| 4 |
GE Aerospace
GE
|
+$89M |
| 5 |
ConocoPhillips
COP
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.82% |
| 2 | Financials | 16.13% |
| 3 | Industrials | 13.26% |
| 4 | Healthcare | 11.06% |
| 5 | Consumer Discretionary | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Eldorado Gold
EGO
$8.37B
| $34.5M | 0.01% |
3,334,912
+544,764
| +20% | +$5.07M |
|
1602
Medifast
MED
$108M
| $34.5M | 0.01% |
332,739
-2,386
| -0.7% | -$264K |
|
1603
Cognex
CGNX
$11.2B
| $34.4M | 0.01% |
695,041
+24,887
| +4% | +$1.26M |
|
1604
CRISPR Therapeutics
CRSP
$4.88B
| $34.4M | 0.01% |
759,735
-15,076
| -2% | -$732K |
|
1605
Powell Industries
POWL
$8B
| $34.3M | 0.01% |
2,416,929
+58,455
| +2% | +$810K |
|
|
VBTX
1606
DELISTED
Veritex Holdings
VBTX
| $34.3M | 0.01% |
1,878,755
+233,878
| +14% | +$5.96M |
|
1607
LeMaitre Vascular
LMAT
$2.37B
| $34.2M | 0.01% |
663,907
-3,997
| -0.6% | -$194K |
|
|
LGF.A
1608
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $34.2M | 0.01% |
3,085,845
-414,118
| -12% | -$3.73M |
|
1609
UFP Technologies
UFPT
$2.07B
| $34.1M | 0.01% |
262,976
-39,408
| -13% | -$4.58M |
|
1610
Koppers
KOP
$976M
| $34.1M | 0.01% |
974,874
+72,360
| +8% | +$2.41M |
|
1611
Pembina Pipeline
PBA
$28B
| $34M | 0.01% |
1,050,682
-26,082
| -2% | -$880K |
|
|
CCF
1612
DELISTED
Chase Corporation
CCF
| $34M | 0.01% |
324,376
+8,503
| +3% | +$815K |
|
|
REVG
1613
DELISTED
REV Group
REVG
| $33.9M | 0.01% |
2,830,578
+118,449
| +4% | +$1.48M |
|
1614
PENN Entertainment
PENN
$2.67B
| $33.9M | 0.01% |
1,142,822
-47,021
| -4% | -$1.46M |
|
1615
BJ's Restaurants
BJRI
$1.44B
| $33.9M | 0.01% |
1,162,745
+88,506
| +8% | +$2.76M |
|
1616
Highwoods Properties
HIW
$3.67B
| $33.8M | 0.01% |
1,459,033
+26,832
| +2% | +$723K |
|
1617
Insteel Industries
IIIN
$602M
| $33.8M | 0.01% |
1,216,114
+58,452
| +5% | +$1.7M |
|
1618
VSE Corp
VSEC
$5.81B
| $33.8M | 0.01% |
751,693
+34,204
| +5% | +$1.73M |
|
|
ISEE
1619
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $33.7M | 0.01% |
1,386,533
-47,742
| -3% | -$1.05M |
|
|
VSXY
1620
Victoria's Secret
VSXY
$7.08B
| $33.6M | 0.01% |
984,404
+308,693
| +46% | +$11.4M |
|
1621
Argan
AGX
$8.31B
| $33.6M | 0.01% |
830,653
-10,438
| -1% | -$410K |
|
1622
QuinStreet
QNST
$897M
| $33.6M | 0.01% |
2,115,592
+87,371
| +4% | +$1.38M |
|
1623
Elanco Animal Health
ELAN
$12.8B
| $33.5M | 0.01% |
3,566,084
+482,830
| +16% | +$5.7M |
|
1624
Gorman-Rupp
GRC
$2.19B
| $33.5M | 0.01% |
1,339,832
-12,802
| -0.9% | -$341K |
|
1625
Semtech
SMTC
$11.1B
| $33.3M | 0.01% |
1,381,071
+312,621
| +29% | +$9.78M |
|
Similar funds
Dimensional Fund Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Dimensional Fund Advisors held 3,570 positions worth $297B, up 87,611% from $338M the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dimensional Fund Advisors's Q1 2023 filing shows 79 new, 2,112 increased, 1,113 reduced and 109 closed positions. Its largest new stake was GE HealthCare: 1,253,762 shares worth $103M. The largest sale was Walmart Inc, an estimated $320M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 12% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2023 buy was GE HealthCare: 1,253,762 shares worth $103M.
- Dimensional Fund Advisors added most to Apple in Q1 2023, an estimated $150M increase.
- Dimensional Fund Advisors's biggest Q1 2023 reduction was Walmart Inc, cutting an estimated $320M.
- Dimensional Fund Advisors fully exited Dimensional Emerging Markets Sustainability Core 1 ETF in Q1 2023, selling an estimated $11.3M.
- Dimensional Fund Advisors's ten largest holdings make up 11% of its $297B portfolio in Q1 2023.
- Dimensional Fund Advisors opened 79 new positions and closed 109 in Q1 2023.
- Dimensional Fund Advisors's portfolio value rose 87,611% quarter-over-quarter to $297B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2023, filed 12 May 2023.